Fig. 2.
Fig. 2. CR duration (A) and survival (B) for patients with AML with t(8; 21) with and without CD56 expression.

CR duration (A) and survival (B) for patients with AML with t(8; 21) with and without CD56 expression.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal